Onartuzumab (MetMAb) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity.
Purity:
99.5%
CAS Number:
[1133766-06-9]
* VAT and and shipping costs not included. Errors and price changes excepted
